1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer - The Henderson article reviewed [Can we abandon anthracyclines for early breast cancer patients?]
    Journal Article

    Morris, P. G.; Hudis, C. A.; Dang, C. T.
    Oncology (Norwalk) (2011)

    Fulltext@MSK | Save
  • Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion
    Journal Article

    Kris, M. G.; Urba, S. G.; Schwartzberg, L. S.
    Clinical Advances in Hematology & Oncology (2011)

    Fulltext@MSK | Save
  • A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Kelsen, D.; Shah, M.; Schwartz, G.; Levine, D. A.; Boyd, J.; Capanu, M.; Miron, B.; Klimstra, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America
    Journal Article

    Freifeld, A. G.; Bow, E. J.; Sepkowitz, K. A.; Boeckh, M. J.; Ito, J. I.; Mullen, C. A.; Raad, I. I.; Rolston, K. V.; Young, J. A. H.; Wingard, J. R.
    Clinical Infectious Diseases (2011)

    Fulltext@MSK | Save
  • Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement
    Journal Article

    Erinjeri, J. P.; Fong, A. J.; Kemeny, N. E.; Brown, K. T.; Getrajdman, G. I.; Solomon, S. B.
    Cancer (2011)

    Fulltext@MSK | Save
  • Carboplatin in clinical stage I seminoma: Too much and too little at the same time
    Journal Article

    Bosl, G. J.; Patil, S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer
    Journal Article

    Bonate, P. L.; Cunningham, C. C.; Gaynon, P.; Jeha, S.; Kadota, R.; Lam, G. N.; Razzouk, B.; Rytting, M.; Steinherz, P.; Weitman, S.
    Cancer Chemotherapy and Pharmacology (2011)

    Fulltext@MSK | Save
  • Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
    Journal Article

    Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, M. D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
    Annals of Oncology (2011)

    Fulltext@MSK | Save
  • NCCN task force report: Update on the management of patients with gastrointestinal stromal tumors
    Journal Article

    Demetri, G. D.; von Mehren, M.; Antonescu, C. R.; DeMatteo, R. P.; Ganjoo, K. N.; Maki, R. G.; Pisters, P. W. T.; Raut, C. P.; Riedel, R. F.; Schuetze, S.; more...
    Journal of the National Comprehensive Cancer Network (2010)

    Fulltext@MSK | Save
  • The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum
    Journal Article

    Zivanovic, O.; Sima, C. S.; Iasonos, A.; Hoskins, W. J.; Pingle, P. R.; Leitao, M. M. Jr; Sonoda, Y.; Abu-Rustum, N. R.; Barakat, R. R.; Chi, D. S.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save